The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Sertraline for the Treatment of Depression in Alzheimer Disease
Open accessAbstract
Objective Depression is common in Alzheimer disease (AD), and antidepressants are commonly used for its treatment, however, evidence for antidepressant efficacy in this population is lacking. The authors conducted a multicenter, randomized, placebo-controlled trial titled "Depression in Alzheimer's Disease-2" to assess the efficacy and tolerability of sertraline for depression in AD.Methods One hundred thirty-one participants from five U.S. medical centers with mild-to-moderate AD (Mini-Mental State Examination scores 10-26) and depression of AD were randomized to double-blinded treatment with sertraline (N = 67) or placebo (N = 64), with a target dosage of 100 mg daily. Efficacy was assessed using logistic regressions and mixed effects models in an intention-to-treat analysis with imputation of missing data. Principal outcome measures were modified Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGIC), change in Cornell Scale for Depression in Dementia (CSDD) scores, and remission defined by both mADCS-CGIC score <or=2 and CSDD score <or=6.Results mADCS-CGIC ratings (odd ratio [OR = 1.01], 95% confidence interval [CI]: 0.52-1.97, p = 0.98), CSDD scores (median difference at 12 weeks 1.2, 95% CI: 1.65-4.05, p = 0.41), and remission at 12 weeks of follow-up (OR = 2.06, 95% CI: 0.84-5.04, p = 0.11) did not differ between sertraline (N = 67) and placebo (N = 64). Sertraline-treated patients experienced more adverse events, most notably gastrointestinal and respiratory, than placebo-treated patients.Conclusion Sertraline did not demonstrate efficacy for the treatment depression symptoms in patients with AD. In addition, its use was associated with an increased incidence of adverse events. Thus, selective serotonin reuptake inhibitors may be of limited value for treating depression in patients with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“(b) antidepressant medication causes severe neurological side effects, which reflect antidepressants interfering with brain function, possibly via altering neurotransmitter systems [29-31]”
From Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan (2017) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“While this method of drug discovery has the attractive feature of studying drugs with generally well-characterized safety profiles, it is inherently limited especially in terms of interpreting null results (Rosenberg et al., 2010).”
From Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits? (2015) · cites this paper as Rosenberg et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation after 18+ years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476908 · Cited by 4,072
Multiple Imputation After 18+ Years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.2307/2291635 · Cited by 2,686
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh‐Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., & Tschanz, J. T. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1858 · Cited by 780
Self-citationMultiple Imputation for Nonresponse in Surveys
Campion, W. M., & Rubin, D. B. (1989) · Journal of Marketing Research · doi:10.2307/3172772 · Cited by 775
Exercise Plus Behavioral Management in Patients With Alzheimer Disease
Teri, L. L., Gibbons, L. E., McCurry, S. M., Logsdon, R. G., Büchner, D. M., Barlow, W. E., Kukull, W. A., LaCroix, A. Z., McCormick, W. C., & Larson, E. B. (2003) · JAMA · doi:10.1001/jama.290.15.2015 · Cited by 765
Schneider, L., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, ., Schmitt, F. A., Grundman, M., Thomas, R. G., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00004 · Cited by 646
Self-citation
Research works printed but not linked: 1
- Garre-Olmo, 2002, Carer's burden and depressive symptoms in patients with Alzheimer's disease. State after twelve months, Rev Neurol, 34, 601
Cited by
Sorted by citations
Items 101–200 of 250
Case for and against specificity of depression in Alzheimer's disease
EVEN, C., & Weintraub, D. A. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02108.x · Cited by 23
Self-citationSpalletta, G., Caltagirone, C., Padovani, A., Sorbi, S., Attar, M., Colombo, D., Cravello, L., & on behalf of the E V O L U T I O N study Working Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0089216 · Cited by 22
Lenouvel, E., Tobias, S., Mühlbauer, V., Dallmeier, D., Denkinger, M. D., Klöppel, S., & Schönfeldt‐Lecuona, C. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116114 · Cited by 21
Effects of Psychedelics in Older Adults: A Prospective Cohort Study
Kettner, H., Roseman, L., Gazzaley, A. H., Carhart-Harris, R. L., & Pasquini, L. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.05.007 · Cited by 19
Antidepressant treatment in Alzheimer's disease
Brodaty, H. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61031-3 · Cited by 19
Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia
Wilkins, J. M., & Forester, B. P. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-015-0656-z · Cited by 22
Rivastigmine Patch Ameliorates Depression in Mild AD
Spalletta, G., Gianni, W., Giubilei, F., Casini, A. R., Sancesario, G., Caltagirone, C., & Cravello, L. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318260ab0a · Cited by 19
The Antipsychotic Discontinuation in Alzheimer Disease Trial: Clinical Rationale and Study Design
Devanand, D. P., Mintzer, J. E., Schultz, S. K., Sultzer, D. L., de la Pena, D., Gupta, S., Colon, S., Schimming, C., Pelton, G. H., Andrews, H., et al. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182110563 · Cited by 17
Self-citationSerotonergic drugs for the treatment of neuropsychiatric symptoms in dementia
Magierski, R., & Sobów, T. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1155453 · Cited by 18
Depressive Symptoms in Clinical and Incipient Alzheimer’s Disease
Hsiao, J. J., & Teng, E. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.10 · Cited by 18
Zuidersma, M., Chua, K., Hellier, J. M., Voshaar, R. C. O., & Banerjee, S. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.03.021 · Cited by 18
Drug Class Review: Second-Generation Antidepressants
Gartlehner, G., Hansen, R. A., Reichenpfader, U., Kaminski, A., Kien, C., Strobelberger, M., Noord, M. V., Thieda, P., Thaler, K. J., & Gaynes, B. N. (2011) · Cited by 17
Qi, X., Nizamutdinov, D., Yi, S. S., Wu, E., & Huang, J. H. (2024) · Biomedicines · doi:10.3390/biomedicines12112636 · Cited by 18
Richtlijn diagnostiek en behandeling van dementie
Rikkert, M. G. M. O., van Exel, E. R., Knol, W. G., Lemstra, A. W., Roks, G., & Verhey, F. R. J. (2015) · Research Publications (Maastricht University) · Cited by 17
Byeon, G., Kang, D. W., Kim, Y., Kim, G. H., Kim, K. W., Kim, H.-J., Na, S., Park, K. H., Park, Y. H., Suh, J., et al. (2025) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2025.24.1.24 · Cited by 16
Antipsychotics Do Not Have To Be Used “Off Label” in Dementia
Volicer, L. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.04.006 · Cited by 15
Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients
Marengoni, A., Bianchi, G., Nobili, A., Tettamanti, M., Pasina, L., Corrao, S., Salerno, F., Iorio, A., Marcucci, M., & Mannucci, P. M. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211002353 · Cited by 15
Verdaguer, E. S., Stafford, J., Tuijt, R., & Orgeta, V. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.053 · Cited by 14
Li, C. H., Pollock, B. G., Lyketsos, C. G., Vaidya, V., Drye, L. T., Kirshner, M. A., Sorisio, D. A., & Bies, R. R. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270012445793 · Cited by 14
Self-citationSertraline for the Treatment of Depression in Alzheimer Disease: Genetic Influences
Peters, M. E., Vaidya, V., Drye, L. T., Rosenberg, P. B., Martin, B. K., Porsteinsson, A. P., Frangakis, C., Mintzer, J. E., Weintraub, D. A., Schneider, L. S. S., et al. (2011) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988711422527 · Cited by 14
Self-citationAkgüller, Ö., Balcı, M. A., & Cioca, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010003 · Cited by 13
Toward Better Terminology of Behavioral Symptoms of Dementia
Volicer, L. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.12.007 · Cited by 13
Pharmacological Treatment of Dementia
Hahn, S. J., & Paik, N. (2015) · Brain & Neurorehabilitation · doi:10.12786/bn.2015.8.1.19 · Cited by 13
Antidepressants for older people: What can we learn from the current evidence base?
Katona, C., Bindman, D., & Katona, C. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.05.016 · Cited by 12
A Review of Pharmacological Treatments for Depression in Alzheimer’s Disease
Siarkos, K., Katirtzoglou, E. A., & Politis, A. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-148010 · Cited by 12
Management of Neuropsychiatric Symptoms in Neurocognitive Disorders
Legesse, B., Babadi, B., & Forester, B. P. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160031 · Cited by 13
Putative pathological mechanisms of late-life depression and Alzheimer’s disease
Hasan, S. M. N., Clarke, C., Strand, T., & Bambico, F. R. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148423 · Cited by 13
Nowrangi, M. A., Outen, J. D., Kim, J., Avramopoulos, D., Lyketsos, C. G., & Rosenberg, P. B. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221247 · Cited by 11
Self-citationFernandez, R. S., Arthur, B., Fleming, R., & Perrin, C. (2014) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2014-1646 · Cited by 11
García‐Alberca, J. M., Gris, E., de la Guía, P., & Mendoza, S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215630 · Cited by 12
The Interface Between Depression and Dementia: Where Are We With This Important Frontier?
Lyketsos, C. G. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181c79641 · Cited by 12
Self-citationManagement of neuropsychiatric symptoms in dementia
Martin, M. S., & Mauléon, A. D. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch70 · Cited by 10
Luca, B. D., Canozzi, A., Mosconi, C., Gastaldon, C., Papola, D., Metelli, A., Tedeschi, F., Amaddeo, F., Purgato, M., Solmi, M., et al. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.18 · Cited by 12
Rose, D., Lyketsos, C. G., Rosenberg, P. B., & Nowrangi, M. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00788 · Cited by 12
Self-citationManaging the Behavioral and Psychological Symptoms of Dementia
Mendez, M. F. (2022) · Current Treatment Options in Neurology · doi:10.1007/s11940-022-00715-6 · Cited by 11
Lee, J. H., Byun, M. S., Yi, D., Choe, Y. M., Choi, H. J., Baek, H., Sohn, B. K., Kim, H. J., Lee, Y., Woo, J. I., et al. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000449155 · Cited by 9
Pharmacologic treatment of depression in Alzheimer’s disease
Haußmann, R., & Donix, M. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000439 · Cited by 9
Cognitive and Emotional Dysfunction in Mild Cognitive Impairment
Penna, S. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.004 · Cited by 12
The Interface between Depression and Alzheimer’s Disease. A Comprehensive Approach
Modrego, P. J., de Cerio, L. D., & Lobo, A. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_326_23 · Cited by 9
Dementia: challenges and promising developments
Ballard, C. G., Corbett, A., & Jones, E. L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70304-5 · Cited by 8
Common Psychiatric Problems in Cognitively Impaired Older Patients
Wang, L. Y., Borisovskaya, A., Maxwell, A. L., & Pascualy, M. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.002 · Cited by 8
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K. J., Lux, L. J., Noord, M. V., Mager, U., Gaynes, B. N., Thieda, P., Strobelberger, M., et al. (2011) · Cited by 8
Therapie mit Antipsychotika und Antidepressiva bei Demenzen
Frölich, L., & Hausner, L. (2015) · Der Nervenarzt · doi:10.1007/s00115-014-4178-4 · Cited by 8
Neuropsychiatric Management of Young-Onset Dementias
Shinagawa, S. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.01.004 · Cited by 9
Alzheimer’s Disease Pharmacology
Plascencia‐Villa, G., & Perry, G. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00018-9 · Cited by 6
Pharmacological Treatment of Alzheimer’s Disease
Schneider, L. S. (2012) · Advances in biological psychiatry · doi:10.1159/000335407 · Cited by 7
Self-citationTreating Depression in Older Adults with Dementia
Lenze, E. J. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03357.x · Cited by 7
Lohse, M. J., & Müller-Oerlinghausen, B. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_41 · Cited by 7
Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life Depression
Métivier, L., Vivien, D., Goy, R., Agin, V., Bui, É., & Benbrika, S. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70015 · Cited by 6
Lohse, M. J., Seifert, J., & Bleich, S. (2021) · Springer eBooks · doi:10.1007/978-3-662-63825-5_39 · Cited by 6
Joshi, A., Todd, S., Finn, D. P., McClean, P. L., & Wong‐Lin, K. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01892-9 · Cited by 6
Longmire, C. F., Drye, L. T., Frangakis, C., Martin, B. K., Meinert, C. L., Mintzer, J. E., Munro, C. A., Porsteinsson, A. P., Rabins, P. V., Rosenberg, P. B., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.02.014 · Cited by 6
Self-citationStay the course—is it justified?
Sepehry, A. A., Lee, P. E., Hsiung, G. R., & Jacova, C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60102-0 · Cited by 6
Friedman, J. H., & Weintraub, D. A. (2012) · Neurology · doi:10.1212/wnl.0b013e318250d88c · Cited by 6
Self-citationTreating Depression in Dementia Patients: A Risk or Remedy—A Narrative Review
Sultan, S. (2024) · Geriatrics · doi:10.3390/geriatrics9030064 · Cited by 6
Longitudinal dementia trajectories for Alzheimer’s Disease characterization and prediction
de Mori, A., & Tauber, C. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110241 · Cited by 5
Bhattacharjee, S., Lee, J. K., Vadiei, N., Patanwala, A. E., Malone, D. C., Knapp, S. M., Lo‐Ciganic, W., & Burke, W. J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s241749 · Cited by 5
Kettner, H., Roseman, L., Gazzaley, A., Carhart-Harris, R., & Pasquini, L. (2024) · Research Square · doi:10.21203/rs.3.rs-3977169/v1 · Cited by 5
Frenais, F. L., Vickerstaff, V., Cooper, C., Livingston, G., Stone, P. C., & Sampson, E. L. (2021) · BJPsych Open · doi:10.1192/bjo.2021.21 · Cited by 6
Lohse, M. J., & Müller-Oerlinghausen, B. (2011) · Springer eBooks · doi:10.1007/978-3-642-21992-4_39 · Cited by 4
Lohse, M. J. (2020) · Springer eBooks · doi:10.1007/978-3-662-62168-4_38 · Cited by 4
Lohse, M. J., & Müller-Oerlinghausen, B. (2019) · Springer eBooks · doi:10.1007/978-3-662-59046-1_41 · Cited by 4
Widera, E., Talebreza, S., & Bernacki, R. (2021) · doi:10.1093/med/9780198821328.003.0092 · Cited by 4
Protocolo terapéutico de la depresión en el anciano
Cuenca, S., & Casado, E. M. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70187-1 · Cited by 4
Perspectives Neuropsychiatric symptoms in Alzheimer's disease
Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P. T., Amatniek, J. C., Cedarbaum, J. M., Brashear, R. H., & Miller, D. S. (2011) · Cited by 4
Self-citationNeuropsychiatric Aspects of Alzheimer Dementia
Nowrangi, M. A. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.012 · Cited by 5
Lohse, M. J., & Müller-Oerlinghausen, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-57386-0_41 · Cited by 4
Comorbidity of Cognitive and Mood Disorders: Furthering the Understanding of Heterogeneity
Kales, H. C. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181d26993 · Cited by 4
Antidepressants in Older Adults: Complexities, Confounds and Clinical Effects
Devanand, D. P., & Roose, S. P. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.09.008 · Cited by 4
Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression
Taylor, W. D., Gerlach, A., Szymkowicz, S. M., Gujral, S., & Andreescu, C. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02324-2 · Cited by 3
Watt, J. A., Ismail, Z., Lane, N. E., Seitz, D. P., & Goodarzi, Z. (2026) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-061724-085912 · Cited by 5
Alzenaidi, F., Aldoweesh, O. H., Alghofaili, S., Fadel, A., Lasloom, R. A. A., Alharbi, D., Almalki, F. S., Alkhairi, A. A., Alharbi, M., Alhamdan, N. A., et al. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100389 · Cited by 3
Drug Treatments for Alzheimer’s Disease: Hopes and Challenges
Braidy, N., Poljak, A., Jayasena, T., & Sachdev, P. S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_141 · Cited by 2
Depression in Alzheimer’s disease: consequence or contributing factor?
Mintzer, J. E., & O’Neill, C. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.145 · Cited by 3
Self-citationLohse, M. J., & Müller-Oerlinghausen, B. (2015) · Springer eBooks · doi:10.1007/978-3-662-47186-9_38 · Cited by 3
Jin, M., Ji, X., Zhu, X., Shou, Y., Ge, Z., & Wang, H. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666220922112955 · Cited by 3
Puerto, A. M. H., Russo, C., & Fregni, F. (2018) · Neuromethods · doi:10.1007/978-1-4939-7880-9_9 · Cited by 5
An Update On the Neuropsychiatric Symptoms of Dementia
Herrmann, N. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.41 · Cited by 3
Depression in Alzheimer's Disease
Kwak, Y. T., Yang, Y., & Koo, M. (2014) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2014.13.2.27 · Cited by 3
Immunotherapies: A Treasure Trove of Alzheimer's Disease
Kolay, A., Neelam, N., Gupta, P., Shaikh, A. M., Goel, R., Nagpal, D., & Chitme, H. R. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010308600240709052539 · Cited by 2
Understanding the Bidirectional Relationship between Alzheimer's and Depression
Pannu, A. S., & Goyal, R. K. (2024) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822303361240903075653 · Cited by 4
Sertraline for the Treatment of Depression in Vascular Cognitive Impairment
Weissberger, G. H., Yarns, B. C., Chen, S. T., Narvaez, T. A., Bussel, N., & Sultzer, D. L. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.04.006 · Cited by 2
Cummings, J. L., Zhong, K., Ballard, C. G., Sano, M. C., & Mintzer, J. E. (2025) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2025.100107 · Cited by 2
Self-citationTranslating Geriatric Psychiatry Research into Practice: Coping with Uncertainty
Rapoport, M. J. (2012) · Canadian Geriatrics Journal · doi:10.5770/cgj.15.43 · Cited by 2
Suarez, L. S. K., Shafi, R. M. A., & Lapid, M. I. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1903074 · Cited by 2
Chapter 20. Psychopharmacology
Mulsant, B. H., & Pollock, B. G. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds20 · Cited by 1
Panca, M., Howard, R. J., Cort, E., Rawlinson, C. V., Gould, R. L., Wiegand, M., Downey, A. M., Banerjee, S., Fox, C., Harwood, R., et al. (2024) · BJPsych Open · doi:10.1192/bjo.2024.775 · Cited by 1
Eleni, I., Theofanis, V., Zisis, B., & Stamoula, Ε. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.09.010 · Cited by 1
Shimizu, K., Yasuda, S., Maeshima, H., Ichikawa, T., & Baba, H. (2026) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70109 · Cited by 1
Karp, J. F., Butters, M. A., Crivelli, L., Hermida, A. P., Gastiazoro, M. P., Gatchel, J. R., Gebara, M. A., Gentry, M. T., Mimura, M., Voshaar, R. C. O., et al. (2026) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2026.100226 · Cited by 1
Hellen, F., Supprian, T., Salamon, T., & Lange‐Asschenfeldt, C. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02294.x · Cited by 1
STARKSTEIN, S. E., & Pahissa, J. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6365-7_5 · Cited by 1
Revue des traitements : maladie d’Alzheimer
Lagrange, F. (2010) · Le Pharmacien Hospitalier · doi:10.1016/j.phhp.2010.07.014 · Cited by 1
Ballard, C. G., & Corbett, A. (2012) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2012-100735 · Cited by 1
Vahia, I. V., Kulkarni, G., Meeks, T. W., & Jeste, D. V. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796816.003.0008 · Cited by 2
Ujeyl, M., & Müller-Oerlinghausen, B. (2012) · Der Schmerz · Cited by 1
Lohse, M. J., & Müller-Oerlinghausen, B. (2012) · Springer eBooks · doi:10.1007/978-3-642-29242-2_39 · Cited by 1
Fernandez, R. S., Arthur, B., & Fleming, R. (2013) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2013-946 · Cited by 1
Revue des traitements : maladie d’Alzheimer
Lagrange, F. (2010) · Le Pharmacien Hospitalier · doi:10.1016/j.phhp.2010.07.015 · Cited by 1
Chapter 8. Dementia and Mild Neurocognitive Disorders
Wise, E. A., & Lyketsos, C. G. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds08 · Cited by 1
Self-citation
Metadata
- Authors
- Rosenberg, P. B., Martin, B. K., Frangakis, C., Mintzer, J. E., Weintraub, D., Porsteinsson, A. P., Schneider, L. S., Rabins, P. V., Munro, C. A., Meinert, C. L., Lyketsos, C. G., & Drye, L. T.
- Affiliations
- Johns Hopkins University (US)
- Medical University of South Carolina (US)
- Mental Illness Research, Education and Clinical Centers (US)
- University of Rochester Medicine (US)
- University of Southern California (US)
- Corresponding author
- Rosenberg, Paul B.
- ORCID
- Venue
- The American Journal of Geriatric Psychiatry
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 18
- Issue
- 2
- Pages
- 136-145
- ISSN
- 1064-7481 (ISSN-L)
- PMC
- PMC2842121
- OpenAlex
- W1983522355
- Cited by
- 250
- References
- 36
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 14 · 2023: 5 · 2022: 14 · 2021: 8 · 2020: 9 · 2019: 14 · 2018: 13 · 2017: 14 · 2016: 11 · 2015: 21 · 2014: 21 · 2013: 24 · 2012: 24
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Geriatric Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01mh068014-05, 5u01mh066176-05, 5u01mh066174-05, 5u01mh066177-05, 5u01mh066175-05)
- National Institute on Aging (K08AG029157, P50AG005142, P50AG005146)
- National Institute of Mental Health (U01 MH068014, U01 MH066174, 1U01MH066175, 1U01MH068014, U01MH066177, 1U01MH066177, 1U01MH066176, U01 MH066175, 1U01MH066174, U01 MH066176, U01MH066136)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- sertraline, Alzheimer's disease, depression, selective serotonin reuptake inhibitors, antidepressant efficacy, adverse events, depression remission, Cornell Scale for Depression in Dementia, mild to moderate dementia
- MeSH terms
- Assessment of Medication Adherence, Aged, Alzheimer Disease, Depression, Double-Blind Method, Female, Humans, Male, Patient Dropouts, Placebos, Treatment Outcome, Drug Monitoring, Selective Serotonin Reuptake Inhibitors, Sertraline, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
